3 Result: Sanofi
Acuity Brands Posts Mixed Results; Sanofi, Teva Ink Anti-TL1A Therapy Deal
October 04th, 2023
Acuity Brands, Inc. (NYSE: AYI) posted fourth-quarter fiscal 2023 earnings of $3.97 per share, surpassing the consensus EPS estimate of $3.72. Quarterly sales for the company totaled $1.01 billion, slightly below analysts' revenue projections of $1.0. Read more
Breaking: Sanofi's Legal Win, Innovative Eyewear's License Deal
June 20th, 2023
Shares of Sanofi (Nasdaq: SNY) surged in pre-market trading following the announcement of a favorable outcome in an International Chamber of Commerce dispute. The tribunal ruled in favor of Sanofi, dismissing Boehringer Ingelheim's. Read more
Innate Pharma, Sanofi: FDA Grants FTD to SAR'579/IPH6101; Hyzon Motors Posts Q1 Loss - IPHA, HYZN News
June 08th, 2023
Innate Pharma (Nasdaq: IPHA) shared important news from Sanofi (Nasdaq: SNY) regarding the U.S. Food and Drug Administration (FDA) granting Fast Track Designation for SAR'579 / IPH6101 to treat hematological malignancies. The FDA's Fast Trac. Read more
Want To Find Some News?
News By Industries
Recent Post
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login